Los Angeles, Calif. – January 16, 2015 — NantHealth, the transformational healthcare cloud-based IT company renowned for measurable progress in converging science and technology through a single integrated clinical platform, today announced the appointment of Gary Palmer, M.D., J.D., MBA, MPH, to the newly created position of chief medical officer (CMO), effective immediately.
“Gary brings to the role of CMO myriad of perspectives and experiences, gained as an executive, academic and practicing oncologist,” said Dr. Patrick Soon-Shiong, chairman and chief executive officer of NantHealth. “He has held senior level positions in drug development, medical affairs and public health, for a number of highly regarded organizations in the broad healthcare field. Gary’s successful track record will benefit NantHealth as we continue to advance our initiatives currently underway and evaluate others.”
“NantHealth is at the leading edge of the recent explosion in genomic and proteomic knowledge in cancer and other fields,” said Palmer. “I am excited to join NantHealth and look forward to utilizing my background and experience to help bring about the vision of fully integrated medical care based on real-time learning.”
Palmer previously served as senior vice president, Medical Affairs, at Foundation Medicine, where he helped launch the FoundationOne assay. Before that, he was chief medical officer of On-Q-ity, a circulating tumor cell company. Earlier, he was vice president of medical affairs at Genomic Health, Inc., where he was instrumental in the commercialization of the Oncotype DX Breast Cancer Assay. Palmer held leadership positions at Kosan Biosciences, Salmedix and Amgen, where he was involved in the clinical development and commercialization of Neupogen, Neulasta and Aranesp.
Prior to joining industry, Palmer served as director of the Medical Breast Service at the University of California Davis Cancer Center and chief of medical oncology at Mercy Health System, Sacramento. He earned a bachelor of arts degree from Yale University and a medical degree from the Stanford University School of Medicine. He completed his oncology training at the Massachusetts General Hospital. Palmer also holds a master of business administration degree from the University of California, Davis, a master of public health degree from the University of California, Los Angeles, and a juris doctorate degree from Concord University. He is a licensed physician and a member of the State Bar of California.
NantHealth is a transformational healthcare company converging biomolecular medicine and bioinformatics with technology services to empower physicians, patients, payers, pharma and researchers to transcend the traditional barriers of today’s healthcare system. NantHealth solutions are advancing diagnostics to better identify and target specific disease characteristics; transforming clinical and operational delivery with real time actionable clinical data, and promoting wellness for a healthier, happier world. We are building an integrated, evidence-based, omics-informed, personalized approach to the delivery of care and the development of next generation healthcare solutions. For more information please visit nanthealth.com and follow Dr. Soon-Shiong on Twitter@solvehealthcare.